4180501/2025-AQ. CENTRAL G155 - GOSERELIN 3.6 MG IMPLANT
About This Opportunity
TranslatedThis tender, referenced as 4180501/2025-AQ. CENTRAL, pertains to the acquisition of Goserelin 3.6 mg implant. Goserelin is a synthetic hormone analogue used in the treatment of certain hormone-sensitive cancers, such as prostate cancer and breast cancer, as well as for benign gynecological conditions like endometriosis and uterine fibroids. The specific formulation required is a 3.6 mg implant, which is a long-acting depot injection designed for sustained release of the medication over a period of time. The tender likely originates from a central procurement entity or a hospital pharmacy, indicated by 'CENTRAL G155'. The objective is to secure a supply of this critical medication for patient treatment. The tender documents will specify the exact pharmaceutical requirements, including dosage form, strength, packaging, expiry dates, and any specific quality or regulatory compliance standards. This procurement is vital for ensuring that patients undergoing treatment for relevant medical conditions have access to this essential medication. The year 2025 in the reference likely indicates the intended period of supply or contract award.
This is a supplies contract in the health and medical services, trade and industry and general supplies sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 15,334.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified by reference 4180501/2025-AQ, concerns the procurement of Goserelin 3.6 mg implantable service, specifically designated as "CENTRAL G155". The contracting authority, operating within Portugal, is seeking to acquire this pharmaceutical product for its medical services. The tender information is centralized through the Portal BASE, which serves as the official platform for public contracts in mainland Portugal and its autonomous regions.
This procurement falls under the category of medical supplies and pharmaceuticals, requiring suppliers to demonstrate their capacity to provide high-quality, registered medicinal products. Typical requirements for such tenders include adherence to stringent regulatory standards, such as those mandated by the European Medicines Agency (EMA) and national health authorities. Bidders will likely need to present evidence of product authorization, manufacturing compliance (e.g., Good Manufacturing Practices - GMP), and a robust supply chain management system to ensure timely and reliable delivery. Furthermore, detailed product specifications, including dosage, formulation, packaging, and expiry dates, will be critical. The contracting authority will be evaluating submissions based on technical merit, compliance with specifications, and commercial competitiveness. This tender represents an opportunity for pharmaceutical manufacturers and distributors to engage with the Portuguese public healthcare sector.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 12, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Arco Ribeirinho, E.P.E.
Unidade Local de Saúde do Arco Ribeirinho, E.P.E. has issued 554 procurement notices on BidsFactory, including 2 currently open and 548 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to PLS PHARMA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Arco Ribeirinho, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €15,334. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.